griseofulvin and Obesity

griseofulvin has been researched along with Obesity* in 1 studies

Other Studies

1 other study(ies) available for griseofulvin and Obesity

ArticleYear
Generalised papular variant of elastolytic giant cell granuloma.
    BMJ case reports, 2019, Dec-16, Volume: 12, Issue:12

    Elastolytic giant cell granuloma (EGCG), also known as actinic granuloma, is an uncommon granulomatous dermatosis usually characterised by asymptomatic annular plaques on sun-exposed skin. Its aetiology is not fully elucidated, but actinic damage has been considered the main causal factor. Atypical variants with lesions in a non-photodistributed pattern are rare and often related to a systemic disorder, suggesting a more complex pathogenesis and demanding for a screening work-up. Herein, we report a case of an adult obese, diabetic woman presenting with a generalised pruritic papular eruption, histologically revealing an elastolytic giant cell granuloma, with a good response to treatment. In this case, the dermatosis was probably associated with her metabolic comorbidities.

    Topics: Aged; Diabetes Complications; Granuloma Annulare; Granuloma, Giant Cell; Griseofulvin; Humans; Hydroxychloroquine; Obesity; Treatment Outcome

2019